期刊文献+

双敏感性壳聚糖接枝聚合物的制备及载药性能研究 被引量:2

Preparation and drug loading of double-sensitive chitosan grafted polymer
下载PDF
导出
摘要 以具有良好生物相容性和pH敏感性的壳聚糖(CS)为基材,结合可逆加成断裂链转移(RAFT)聚合接枝温敏性聚合物N-异丙基丙烯酰胺(NIPAM),合成一种双敏感的CS接枝聚合物(CS-g-PNIPAM)。用傅里叶红外光谱仪(FT-IR)、扫描电子显微镜(SEM)、透射电镜(TEM)、核磁(H1 NMR)对聚合物的结构和形态进行表征,用变温紫外考察其温敏性,并用来包裹抗癌药物紫杉醇(PTX)。通过物理吸附的方式,将抗癌药物PTX包裹进CS-gNIPAM纳米颗粒(NPs)中制备载药纳米颗粒(CS-g-PNIPAM-PTX)。实验结果表明,CS-g-PNIPAM成功制备,低临界溶解温度(LCST)为30℃,平均粒径为100nm;载药纳米颗粒CS-g-PNIPAM-PTX NPs具有相对较高的药物负载效率(8.1%),在pH=7.4和25℃时,PTX的释放缓慢;但在pH=5.0和37℃时,释放速度大大加快。 A dual sensitive chitosan grafted polymer(CS-g-PNIPAM)was synthesized used chitosan with good biocompatibility and pH sensitivity as the substrate,grafting thermosensitive polymer by combined with reversible addition and fracture chain transfer(RAFT)polymerization.The structure and morphology of grafted polymer was characterized by fourier transform infrared spectroscopy(FT-IR),scanning electron microscopy(SEM),transmission electron microscopy(TEM)and nuclear magnetic resonance(1 H-NMR).The temperature sensitivity of block polymer was investigated by UV irradiation.Used to wrap anticancer drug paclitaxel,the results showed that CS-g-PNIPAM with low critical solution temperature(LCST)of 30℃and average particle size of 100 nm was successfully prepared.CS-g-PNIPAM-PTX NPs had a relatively high drug loading efficiency(8.1%).At pH 7.4 and 25℃,the release of PTX was slow but significantly accelerated at pH 5.0 and 37℃.
作者 钱倩倩 牛世伟 章学易 朱利民 Qian Qianqian;Niu Shiwei;Zhang Xueyi;Zhu Limin(College of Chemistry,Chemical Engineering and Biotechnology,Donghua University,Shanghai 201620)
出处 《化工新型材料》 CAS CSCD 北大核心 2019年第3期236-241,共6页 New Chemical Materials
基金 国家自然科学基金资助项目(21303014) 中央高校基本科研业务经费 东华-伦敦都市大学中英药用纺织品联合实验室
关键词 壳聚糖 RAFT聚合 温敏性 药物缓释 chitosan RAFT polymerization thermosensitiver drug sustained-release
  • 相关文献

参考文献3

二级参考文献32

  • 1万荣欣,顾汉卿.水溶性壳聚糖的研究进展[J].透析与人工器官,2005,16(1):26-32. 被引量:9
  • 2任东文,包德才,王为,马小军.N-乙酰化壳聚糖的FTIR和XRD研究[J].光谱学与光谱分析,2006,26(7):1217-1220. 被引量:16
  • 3蒋挺大.壳聚糖[M].北京:化学工业出版社,2003,7..
  • 4宋巍,陈元维,史国齐,张小华,余喜讯,万昌秀.不同脱乙酰度壳聚糖的制备及结构性能的研究[J].功能材料,2007,38(10):1705-1708. 被引量:27
  • 5Bergmann T K,Green H,Brasch-Andersen C,et al. Retrospective study of the impact ofpharmacogenetic variants on paclitaxel toxicity and survival in patients with ovarian cancer[J]. EuropeanJournal of Clinical Pharmacology , 2011,67(1) : 693-700.
  • 6Chopra A,Kim T S I O S,Martinez D,et al. Combined therapy of an established,highly aggressivebreast cancer in mice with paclitaxel and a unique DNA-based cell vaccine [J]. Int J Cancer, 2006,118(11): 2888-2898.
  • 7Stathopoulos G P, Katis C,Tsavdaridis D,et al. Front-line paclitaxel and topotecan chemotherapy inadvanced or metastatic non-small-cell lung cancer: a phase II trial [J]. Cancer Chemotherapy andPharmacology , 2006,58(11) : 555-560.
  • 8Iesalnieks I,Tange S,Scherer M N, et al. Paclitaxel promotes liver graft survival in rats and inhibitshepatocellular carcinoma growth in vitro and is a potentially useful drug for transplant patients with livercancer[J]. TVansf/a.^ _Proc,2002,34(6) : 2316-2317.
  • 9Spencer C M,Faulds D. Paclitaxel-a review of its pharmacodynamic and pharmacokinetic properties andtherapeutic potential in the treatment of cancer[J]. Drug,1994,48(5) : 794-847.
  • 10Liggins R T,Burt H M. Polyether-polyester diblock copolymers for the preparation of paclitaxel loadedpolymeric micelle formulations [J], Advanced Drug Delivery Reviews,2002,54(2) : 191-202.

共引文献10

同被引文献9

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部